Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 29;18(11):e0294556.
doi: 10.1371/journal.pone.0294556. eCollection 2023.

Factors associated with SARS-COV-2 positive test in Lifelines

Grigory Sidorenkov  1 , Judith M Vonk  1 , Marco Grzegorczyk  2 , Francisco O Cortés-Ibañez  1 , Geertruida H de Bock  1
Affiliations

Factors associated with SARS-COV-2 positive test in Lifelines

Grigory Sidorenkov et al. PLoS One. .

Erratum in

Abstract

Background: Severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) can affect anyone, however, it is often mixed with other respiratory diseases. This study aimed to identify the factors associated with SARS-COV-2 positive test.

Methods: Participants from the Northern Netherlands representative of the general population were included if filled in the questionnaire about well-being between June 2020-April 2021 and were tested for SARS-COV-2. The outcome was a self-reported test as measured by polymerase chain reaction. The data were collected on age, sex, household, smoking, alcohol use, physical activity, quality of life, fatigue, symptoms and medications use. Participants were matched on sex, age and the timing of their SARS-COV-2 tests maintaining a 1:4 ratio and classified into those with a positive and negative SARS-COV-2 using logistic regression. The performance of the model was compared with other machine-learning algorithms by the area under the receiving operating curve.

Results: 2564 (20%) of 12786 participants had a positive SARS-COV-2 test. The factors associated with a higher risk of SARS-COV-2 positive test in multivariate logistic regression were: contact with someone tested positive for SARS-COV-2, ≥1 household members, typical SARS-COV-2 symptoms, male gender and fatigue. The factors associated with a lower risk of SARS-COV-2 positive test were higher quality of life, inhaler use, runny nose, lower back pain, diarrhea, pain when breathing, sore throat, pain in neck, shoulder or arm, numbness or tingling, and stomach pain. The performance of the logistic models was comparable with that of random forest, support vector machine and gradient boosting machine.

Conclusions: Having a contact with someone tested positive for SARS-COV-2 and living in a household with someone else are the most important factors related to a positive SARS-COV-2 test. The loss of smell or taste is the most prominent symptom associated with a positive test. Symptoms like runny nose, pain when breathing, sore throat are more likely to be indicative of other conditions.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Overview of the procedure followed to reduce class imbalance (equalization strategy).
* Continuous variables were rescaled to the interval between zero and one; AUC–Area Under the Curve.
Fig 2
Fig 2. Logistic regression representing the associations between the characteristics of participants and test outcome for SARS-COV-2 infection.
See this image and copyright information in PMC

References

    1. Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, et al.. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS One. 2021. Mar 4;16(3):e0247461. doi: 10.1371/journal.pone.0247461 ; PMCID: PMC7932512. - DOI - PMC - PubMed
    1. Cummins L, Ebyarimpa I, Cheetham N, Tzortziou Brown V, Brennan K, Panovska-Griffiths J. Factors associated with COVID-19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data. Influenza Other Respir Viruses. 2021. Sep;15(5):577–588. doi: 10.1111/irv.12864 Epub 2021 May 4. ; PMCID: PMC8242436. - DOI - PMC - PubMed
    1. Bennett KE, Mullooly M, O’Loughlin M, Fitzgerald M, O’Donnell J, O’Connor L, et al.. Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study. Lancet Reg Health Eur. 2021 Jun;5:100097. doi: 10.1016/j.lanepe.2021.100097 Epub 2021 Apr 15. ; PMCID: PMC8049357. - DOI - PMC - PubMed
    1. Rostami A, Sepidarkish M, Leeflang MMG, Riahi SM, Nourollahpour Shiadeh M, Esfandyari S, et al.. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis. Clin Microbiol Infect. 2021 Mar;27(3):331–340. doi: 10.1016/j.cmi.2020.10.020 Epub 2020 Oct 24. ; PMCID: PMC7584920. - DOI - PMC - PubMed
    1. Jacob L, Koyanagi A, Smith L, Haro JM, Rohe AM, Kostev K. Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021. Int J Infect Dis. 2021. Oct;111:37–42. doi: 10.1016/j.ijid.2021.08.010 Epub 2021 Aug 9. ; PMCID: PMC8413670. - DOI - PMC - PubMed